Pro-Pointer, Inc. Introduces Revolutionary New Energy Drink, Annual Revenues Could Exceed $50 Million Dollars
24 August 2010 - 6:00AM
Marketwired
Pro Pointer, Inc. (PINKSHEETS: PPII), through its wholly owned
subsidiary Coenzyme-A Technologies, Inc., is pleased to announce
its latest innovative proprietary formulation, the COENZYME-A
"Body Energizer Drink"™. The formula contains
a balanced combination of active nutritional components, cognitive
enhancers and cellular energy promoting nutrients, immune system
boosters and detoxifying agents, into an appealing and tasty
beverage for consumers.
"In contrast to today's sugar and caffeine stimulant drinks that
can create a high/low energy cycle, including a spike in the
insulin levels of the consumer, the Coenzyme-A 'Body Energizer Drink'™ is a whole
body, mind, and natural mood enhancing energy drink that is not
addictive, does not affect the natural sleeping patterns, and has
no adverse side effects while maintaining energy levels and
preventing hunger and weakness," stated Nickolaos D. Skouras, PhD,
President/CEO of Coenzyme-A Technologies, Inc. "We are confident
this is the first nutraceutical energy drink to combine nutritional
components that can be used by the body to support its manufacture
and utilization of Acetyl Coenzyme-A with a specific set of
substrates that are designed to assist the body in stabilizing
blood sugar levels while increasing energy and alertness," Dr.
Skouras added.
The world nutraceutical market, which is expected to top $15
billion this year, has enjoyed double-digit growth over the last
few years and is expected to continue. Growth is believed to be
driven by new product introductions and health consciousness within
the aging populations. The US baby boomers, which are expected to
reach 80 million by 2012, drive the US market in the sense that
they are the generation which is most likely to demand control over
the course of their medical care. Coenzyme-A Technologies, Inc.
plans to penetrate this market through new and existing
distribution channels as well as the implementation of an
aggressive world-wide internet marketing campaign.
The national Energy Beverage Market well exceeds a Billion
Dollars annually. A comparable Energy Drink (in price only and not
quality) "The 5-Hour Energy drink" reports weekly sales of over
four million bottles that translates to gross sales of over $48
Million per month, and $576 Million per year. Given the above
current statistics, the Coenzyme-A "Body Energizer
Drink"™ when properly advertised and promoted to reach
consumer awareness could well exceed $50 Million in annual
revenue.
ABOUT COENZYME-A TECHNOLOGIES, INC. --
Coenzyme-A Technologies, Inc. is an innovative company that
has applied new technology to the formulation and manufacture of a
series of proprietary products which address nutritional
deficiencies that result from the stress of modern day living,
chemical imbalances within the body, and the deleterious effects of
aging. Coenzyme-A is the first nutraceutical product to combine
nutritional components that can be successfully used by the body to
support its manufacture and utilization of cellular Coenzyme-A (The
Master Coenzyme). Coenzyme-A contains a specific set of substrates
that are designed to assist the body in converting fats,
carbohydrates and proteins into energy at the cellular level.
See Company website -- www.coenzyme-a.com.
FORWARD-LOOKING STATEMENTS The information contained in this
news release, other than historical information, consists of
forward-looking statements within the meaning of Section 27A of the
Securities Act and Section 21E of the Exchange Act. These
statements may involve risks and uncertainties that could cause
actual results to differ materially from those described in such
statements. Such forward-looking statements involve known and
unknown risks and uncertainties, including all business
uncertainties relating to product development, marketing, market
acceptance, future capital requirements, competition in general and
other factors that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. The Company is under no obligation to (and
expressly disclaims any such obligation to) update or alter its
forward-looking statements whether as a result of new information,
future events or otherwise.
Contact Information: Pro-Pointer, Inc. 458 Coral Sea St.
Henderson, Nv. 89074 Ph- 702-458-4111 Cell-702-591-7440
Coenzyme A (CE) (USOTC:PPII)
Historical Stock Chart
From Nov 2024 to Dec 2024
Coenzyme A (CE) (USOTC:PPII)
Historical Stock Chart
From Dec 2023 to Dec 2024